For an adult with a serious intra‑abdominal or pelvic infection, what vancomycin dose (mg per kilogram) and target area under the concentration‑time curve (AUC) should be used?

Vancomycin Dosing for Intra-Abdominal/Pelvic Infections

For serious intra-abdominal or pelvic infections in adults, use vancomycin 15-20 mg/kg IV every 8-12 hours (based on actual body weight) targeting an AUC₂₄/MIC ≥400 mg·h/L, which typically corresponds to trough concentrations of 15-20 mg/L for complicated infections. 1, 2

Dosing Strategy

Initial Loading and Maintenance Dosing

• Loading dose: While not explicitly required in guidelines, consider 25-30 mg/kg for serious infections to achieve rapid therapeutic levels 2
• Maintenance dose: 15-20 mg/kg every 8-12 hours based on actual body weight 1, 2
  • For patients with normal renal function (CrCl 70-100 mL/min), this typically means doses exceeding the traditional 1g every 12 hours
  • Doses >1g should be infused over 1.5-2 hours to minimize infusion-related reactions 1

Target AUC and Trough Levels

The primary pharmacodynamic target is AUC₂₄/MIC ≥400 mg·h/L 1, 2. For complicated infections including intra-abdominal/pelvic infections:

• Target trough: 15-20 mg/L to achieve AUC₂₄/MIC ≥400 when MIC ≤1 mg/L 1, 2
• This trough range is specifically recommended for bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia, and complicated skin/soft tissue infections 1, 2

Critical caveat: Recent evidence shows vancomycin penetration into bile is markedly limited (only 18.5% penetration) compared to ascitic fluid (66% penetration) 3. For biliary infections specifically, consider alternative anti-Gram-positive agents or site-specific therapeutic drug monitoring.

Monitoring Approach

Timing of Levels

• Measure steady-state trough concentration just before the fourth dose 1
• For short courses (≤5 days) or lower-intensity dosing (trough <15 mg/L), frequent monitoring is not required 1

AUC Calculation

• Use Bayesian software or two-level pharmacokinetic equations for AUC estimation 2
• Trough-only monitoring may be inadequate: 75% of trough/AUC pairs show discordance 4
• When trough is 15-20 mg/L, AUC₂₄ exceeds 600 mg·h/L in 69% of cases, potentially causing unnecessary toxicity 4

Special Populations

Obesity (BMI ≥30 kg/m²)

• Use actual body weight for dosing calculations 1, 2
• Loading dose ~20 mg/kg (ceiling 2g) achieves target AUC₀₋₂₄ in 50% of patients 5, 6
• Younger, heavier patients are frequently underexposed with standard dosing 5
• Maintenance doses may require 9.2-26.3 mg/kg/day depending on renal function 6

Renal Impairment

• Mandatory dose adjustment based on creatinine clearance 7
• Initial dose should be ≥15 mg/kg even with mild-moderate renal dysfunction 7
• Older patients with chronic kidney disease are at high risk for supratherapeutic exposure 5

Safety Considerations

Nephrotoxicity Definition

Vancomycin-induced nephrotoxicity requires:

• ≥2-3 consecutive elevated serum creatinine measurements (increase ≥0.5 mg/dL or ≥50% from baseline) 1
• After several days of therapy
• Without alternative explanation

Risk Mitigation

• AUC₂₄ >540-580 mg·h/L independently predicts acute kidney injury 8
• Monitor trough concentrations in high-risk patients: morbidly obese, renal dysfunction, fluctuating volumes of distribution 2
• Peak concentration monitoring does NOT reduce nephrotoxicity and is not recommended 1

Practical Algorithm

1. Calculate loading dose: 20-25 mg/kg (actual body weight), maximum 2g
2. Calculate maintenance dose: 15-20 mg/kg every 8-12 hours based on renal function
3. Obtain trough before 4th dose for serious infections
4. Target trough 15-20 mg/L for complicated intra-abdominal infections
5. Consider AUC calculation if available, targeting 400-600 mg·h/L
6. For biliary infections specifically: strongly consider alternative agents due to poor vancomycin penetration 3

Important Limitations

The evidence supporting AUC₂₄/MIC ≥400 is Level III (expert opinion) with Grade B recommendation 1. The single study establishing this target involved only lower respiratory tract infections 2. Recent data suggest lower trough targets (10-14 mg/L) may achieve adequate AUC for many infections while reducing toxicity 4, 8, but guidelines have not yet incorporated this finding.

For intra-abdominal infections specifically, newer evidence suggests optimal targets may be AUC₂₄ 370-540 mg·h/L and trough 10-14 mg/L 8, though this requires validation in larger trials.